BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261102T080000
DTEND;TZID=America/New_York:20261102T093000
DTSTAMP:20261021T144254Z
CREATED:20260924T171712Z
LAST-MODIFIED:20261021T144254Z
UID:3604-1793606400-1793611800@lifescievents.com
SUMMARY:NovaBridge Biosciences Virtual KOL Event - China User Stream
DESCRIPTION:Join NovaBridge Biosciences for a virtual key opinion leader (KOL) event featuring Samuel J. Klempner\, MD (Associate Professor of Medicine at Massachusetts General Hospital) who will join company management to discuss expanded Phase 1b safety and efficacy data for givastomig\, a Claudin 18.2 x 4-1BB bispecific antibody\, in combination with nivolumab and chemotherapy in the first-line treatment of Claudin 18.2-positive gastroesophageal adenocarcinoma. The data will be presented at the ESMO Congress 2026\, taking place October 23-27 in Madrid\, Spain.\n\nDr. Klempner will discuss the clinical significance of the updated data\, the unmet need in first-line gastric and gastroesophageal cancers\, and the potential role of givastomig in CLDN18.2-positive disease.\n \nNovaBridge management will also discuss the maturation of the clinical dataset\, regulatory progress\, ongoing FDA interactions\, and the considerations informing future development planning for the program.\n \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/fh63jp/.
URL:https://lifescievents.com/event/fh63jp/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/09/NovaBridge-Manner-1-1.png
END:VEVENT
END:VCALENDAR